Khiron Life Sciences Corp.
KHRNF · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$33,594 | -$23,950 | -$36,355 | -$19,807 |
| Dep. & Amort. | $1,115 | $1,167 | $939 | $338 |
| Deferred Tax | $0 | $0 | $0 | $79 |
| Stock-Based Comp. | $2,322 | $5,716 | $9 | $0 |
| Change in WC | -$2,327 | -$1,939 | -$3,182 | $1,327 |
| Other Non-Cash | $12,084 | -$5,527 | $8,515 | $0 |
| Operating Cash Flow | -$20,400 | -$24,532 | -$30,075 | -$14,774 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,744 | -$2,693 | -$6,095 | -$3,826 |
| Net Acquisitions | -$0 | $0 | -$2,831 | -$1,445 |
| Inv. Purchases | $0 | $0 | -$23,051 | -$3,950 |
| Inv. Sales/Matur. | $0 | $27,560 | $23,051 | $0 |
| Other Inv. Act. | -$342 | $0 | -$23,051 | $0 |
| Investing Cash Flow | -$2,086 | $24,867 | -$31,976 | -$9,220 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$107 | -$1 | -$1,273 | $0 |
| Stock Issued | $11,002 | $12,940 | $53,139 | $22,833 |
| Stock Repurch. | $0 | -$212 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$555 | $5,129 | $14,752 |
| Financing Cash Flow | $10,895 | $12,172 | $56,995 | $37,585 |
| Forex Effect | -$1,136 | -$202 | -$613 | -$387 |
| Net Chg. in Cash | -$12,726 | $12,304 | -$5,669 | $13,204 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21,649 | $9,345 | $15,014 | $1,810 |
| End Cash | $8,923 | $21,649 | $9,345 | $15,014 |
| Free Cash Flow | -$22,144 | -$27,225 | -$36,170 | -$18,600 |